Estrella Immunopharma (ESLAW) Competitors

$0.10

0.00 (0.00%)

(As of 09/6/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Trends

ESLAW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying Estrella Immunopharma stock or one of its competitors? The main competitors of Estrella Immunopharma include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

Estrella Immunopharma vs.

Estrella Immunopharma (NASDAQ:ESLAW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, community ranking, valuation, media sentiment, earnings and analyst recommendations.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Estrella Immunopharma N/A N/A N/A N/A N/A
180 Life Sciences N/A N/A N/A N/A N/A
: In the previous week, Estrella Immunopharma's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.
Company Overall Sentiment
Estrella Immunopharma Neutral
180 Life Sciences Neutral
: Estrella Immunopharma and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
Estrella Immunopharma N/A N/A
180 Life Sciences N/A N/A
: Company Net Margins Return on Equity Return on Assets
Estrella Immunopharma N/A N/A N/A
180 Life Sciences N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Estrella Immunopharma
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
180 Life Sciences
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Estrella Immunopharma	N/A	N/A	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Estrella Immunopharma	Neutral
180 Life Sciences	Neutral

Company	Underperform	Outperform
Estrella Immunopharma	N/A	N/A
180 Life Sciences	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Estrella Immunopharma	N/A	N/A	N/A
180 Life Sciences	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Estrella Immunopharma	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Estrella Immunopharma and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Ad DTI

How a $0.25 cent option contract makes my top traders feel

If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…

Click now to see for yourself what $0.25 Cent Trades is all about

Get Estrella Immunopharma News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ESLAW vs. The Competition

Export to Excel

Metric	Estrella Immunopharma	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$150.41M	$5.69B	$7.88B
Dividend Yield	N/A	3.51%	2.73%	4.02%
P/E Ratio	N/A	110.87	112.07	17.89
Price / Sales	N/A	15,491.35	1,780.86	79.14
Price / Cash	N/A	12.46	38.99	32.58
Price / Book	N/A	5.04	5.04	4.46
Net Income	N/A	-$19.57M	$114.87M	$224.46M
7 Day Performance	N/A	-0.14%	-1.52%	-3.60%
1 Month Performance	N/A	3.17%	8.48%	5.28%
1 Year Performance	N/A	12.75%	12.50%	4.44%

Estrella Immunopharma Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-36.0%	$0.00	N/A	7	Gap Down
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars 0.00 / 5 stars	$0.06 flat	N/A	N/A	$0.00	$418,304.00	2
DRTSW Alpha Tau Medical	0 of 5 stars 0.00 / 5 stars	$0.21 -8.9%	N/A	-31.7%	$0.00	N/A	80	Positive News
WENAW Anew Medical	0 of 5 stars 0.00 / 5 stars	$0.05 flat	N/A	N/A	$0.00	N/A	N/A	Gap Up
APLMW Apollomics	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	-83.3%	$0.00	N/A	59	Positive News Gap Up
BCTXW BriaCell Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.23 +9.5%	N/A	-90.0%	$0.00	N/A	8
CDIOW Cardio Diagnostics	0 of 5 stars 0.00 / 5 stars	$0.04 flat	N/A	N/A	$0.00	$39,138.00	7	Gap Down
CTCXW Carmell	0 of 5 stars 0.00 / 5 stars	$0.07 flat	N/A	-66.7%	$0.00	$12,320.00	9
CELUW Celularity	0 of 5 stars 0.00 / 5 stars	$0.02 flat	N/A	-18.1%	$0.00	$22.77M	220
CEROW CERo Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	N/A	$0.00	N/A	8